Persistent Disparities in Survival for Patients with Glioblastoma
- 1 December 2018
- journal article
- research article
- Published by Elsevier in World Neurosurgery
- Vol. 120, e511-e516
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for GlioblastomaJAMA, 2015
- Glioma Groups Based on 1p/19q,IDH, andTERTPromoter Mutations in TumorsNew England Journal of Medicine, 2015
- TERT promoter mutations: a novel independent prognostic factor in primary glioblastomasNeuro-Oncology, 2014
- A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regimeBritish Journal Of Neurosurgery, 2013
- Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic StrategiesArchivum Immunologiae et Therapiae Experimentalis, 2012
- Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?Radiation Oncology, 2011
- Malignant Gliomas in AdultsNew England Journal of Medicine, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005